BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

306 related articles for article (PubMed ID: 30139738)

  • 21. NUTM1-rearranged neoplasia: a multi-institution experience yields novel fusion partners and expands the histologic spectrum.
    Stevens TM; Morlote D; Xiu J; Swensen J; Brandwein-Weber M; Miettinen MM; Gatalica Z; Bridge JA
    Mod Pathol; 2019 Jun; 32(6):764-773. PubMed ID: 30723300
    [TBL] [Abstract][Full Text] [Related]  

  • 22. NUT Carcinoma of the Sublingual Gland.
    Andreasen S; French CA; Josiassen M; Hahn CH; Kiss K
    Head Neck Pathol; 2016 Sep; 10(3):362-6. PubMed ID: 26586234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Complex chromosomal rearrangements by single catastrophic pathogenesis in NUT midline carcinoma.
    Lee JK; Louzada S; An Y; Kim SY; Kim S; Youk J; Park S; Koo SH; Keam B; Jeon YK; Ku JL; Yang F; Kim TM; Ju YS
    Ann Oncol; 2017 Apr; 28(4):890-897. PubMed ID: 28203693
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clinical and molecular features of pulmonary NUT carcinoma characterizes diverse responses to immunotherapy, with a pathologic complete response case.
    Chen M; Chen X; Zhang Y; Wang W; Jiang L
    J Cancer Res Clin Oncol; 2023 Aug; 149(9):6361-6370. PubMed ID: 36752907
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A rare Japanese case with a NUT midline carcinoma in the nasal cavity: a case report with immunohistochemical and genetic analyses.
    Suzuki S; Kurabe N; Minato H; Ohkubo A; Ohnishi I; Tanioka F; Sugimura H
    Pathol Res Pract; 2014 Jun; 210(6):383-8. PubMed ID: 24655834
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chemical Screen Identifies Diverse and Novel Histone Deacetylase Inhibitors as Repressors of NUT Function: Implications for NUT Carcinoma Pathogenesis and Treatment.
    Shiota H; Alekseyenko AA; Wang ZA; Filic I; Knox TM; Luong NM; Huang Y; Scott DA; Jones KL; Gokhale PC; Lemieux ME; Cole PA; Kuroda MI; French CA
    Mol Cancer Res; 2021 Nov; 19(11):1818-1830. PubMed ID: 34285087
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Midline carcinoma of children and young adults with NUT rearrangement.
    French CA; Kutok JL; Faquin WC; Toretsky JA; Antonescu CR; Griffin CA; Nose V; Vargas SO; Moschovi M; Tzortzatou-Stathopoulou F; Miyoshi I; Perez-Atayde AR; Aster JC; Fletcher JA
    J Clin Oncol; 2004 Oct; 22(20):4135-9. PubMed ID: 15483023
    [TBL] [Abstract][Full Text] [Related]  

  • 28. NUTM1 -rearranged Carcinoma of the Thyroid : A Distinct Subset of NUT Carcinoma Characterized by Frequent NSD3 - NUTM1 Fusions.
    Barletta JA; Gilday SD; Afkhami M; Bell D; Bocklage T; Boisselier P; Chau NG; Cipriani NA; Costes-Martineau V; Ghossein RA; Hertzler HJ; Kramer AM; Limaye S; Lopez CA; Ng TL; Weissferdt A; Xu B; Zhang S; French CA
    Am J Surg Pathol; 2022 Dec; 46(12):1706-1715. PubMed ID: 36040068
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628.
    Stathis A; Zucca E; Bekradda M; Gomez-Roca C; Delord JP; de La Motte Rouge T; Uro-Coste E; de Braud F; Pelosi G; French CA
    Cancer Discov; 2016 May; 6(5):492-500. PubMed ID: 26976114
    [TBL] [Abstract][Full Text] [Related]  

  • 30. NUT Carcinoma in a Patient with Unusually Long Survival and False Negative FISH Results.
    McLean-Holden AC; Moore SA; Gagan J; French CA; Sher D; Truelson JM; Bishop JA
    Head Neck Pathol; 2021 Jun; 15(2):698-703. PubMed ID: 32918711
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Activation of SOX2 expression by BRD4-NUT oncogenic fusion drives neoplastic transformation in NUT midline carcinoma.
    Wang R; Liu W; Helfer CM; Bradner JE; Hornick JL; Janicki SM; French CA; You J
    Cancer Res; 2014 Jun; 74(12):3332-43. PubMed ID: 24736545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Utility of NUT gene expression and rearrangement in diagnosis of NUT midline carcinoma in upper respiratory tract].
    Fang W; French CA; Cameron MJ; Han YD; Liu HG
    Zhonghua Bing Li Xue Za Zhi; 2012 Aug; 41(8):519-24. PubMed ID: 23157742
    [TBL] [Abstract][Full Text] [Related]  

  • 33. NUT Carcinoma of the Salivary Glands: Clinicopathologic and Molecular Analysis of 3 Cases and a Survey of NUT Expression in Salivary Gland Carcinomas.
    Agaimy A; Fonseca I; Martins C; Thway K; Barrette R; Harrington KJ; Hartmann A; French CA; Fisher C
    Am J Surg Pathol; 2018 Jul; 42(7):877-884. PubMed ID: 29649019
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The expanding universe of NUTM1 fusions in pediatric cancer.
    Charlab R; Racz R
    Clin Transl Sci; 2023 Aug; 16(8):1331-1339. PubMed ID: 37082775
    [TBL] [Abstract][Full Text] [Related]  

  • 35. MYC, a downstream target of BRD-NUT, is necessary and sufficient for the blockade of differentiation in NUT midline carcinoma.
    Grayson AR; Walsh EM; Cameron MJ; Godec J; Ashworth T; Ambrose JM; Aserlind AB; Wang H; Evan G; Kluk MJ; Bradner JE; Aster JC; French CA
    Oncogene; 2014 Mar; 33(13):1736-1742. PubMed ID: 23604113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. BRD-NUT oncoproteins: a family of closely related nuclear proteins that block epithelial differentiation and maintain the growth of carcinoma cells.
    French CA; Ramirez CL; Kolmakova J; Hickman TT; Cameron MJ; Thyne ME; Kutok JL; Toretsky JA; Tadavarthy AK; Kees UR; Fletcher JA; Aster JC
    Oncogene; 2008 Apr; 27(15):2237-42. PubMed ID: 17934517
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Primary Thyroid NUT Carcinoma With High PD-L1 Expression and Novel Massive
    Zhou J; Duan M; Jiao Q; Chen C; Xing A; Su P; Tang J; Zhang H; Liu Z
    Front Oncol; 2021; 11():778296. PubMed ID: 35127482
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clinicopathological and Preclinical Findings of NUT Carcinoma: A Multicenter Study.
    Jung M; Kim S; Lee JK; Yoon SO; Park HS; Hong SW; Park WS; Kim JE; Kim J; Keam B; Kim HJ; Kang HJ; Kim DW; Jung KC; Kim YT; Heo DS; Kim TM; Jeon YK
    Oncologist; 2019 Aug; 24(8):e740-e748. PubMed ID: 30696721
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A novel BRD4-NUT fusion in an undifferentiated sinonasal tumor highlights alternative splicing as a contributing oncogenic factor in NUT midline carcinoma.
    Stirnweiss A; McCarthy K; Oommen J; Crook ML; Hardy K; Kees UR; Wilton SD; Anazodo A; Beesley AH
    Oncogenesis; 2015 Nov; 4(11):e174. PubMed ID: 26551281
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Challenges and Opportunities in NUT Carcinoma Research.
    Hakun MC; Gu B
    Genes (Basel); 2021 Feb; 12(2):. PubMed ID: 33562801
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.